Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 55

1.

Anti-TNF therapy for polymyalgia rheumatica: report of 99 cases and review of the literature.

Aikawa NE, Pereira RM, Lage L, Bonfá E, Carvalho JF.

Clin Rheumatol. 2012 Mar;31(3):575-9. doi: 10.1007/s10067-011-1914-z. Epub 2012 Jan 11. Review.

PMID:
22234490
2.

Treatment of refractory polymyalgia rheumatica with etanercept: an open pilot study.

Catanoso MG, Macchioni P, Boiardi L, Pipitone N, Salvarani C.

Arthritis Rheum. 2007 Dec 15;57(8):1514-9.

3.

TNF-alpha blockade induce clinical remission in patients affected by polymyalgia rheumatica associated to diabetes mellitus and/or osteoporosis: a seven cases report.

Migliore A, Massafra U, Carloni E, Padalino C, Martin Martin S, Lasaracina F, Dibiase N, Alimonti A, Granata M.

Eur Rev Med Pharmacol Sci. 2005 Nov-Dec;9(6):373-8.

PMID:
16479743
4.

Infliximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica: a randomized trial.

Salvarani C, Macchioni P, Manzini C, Paolazzi G, Trotta A, Manganelli P, Cimmino M, Gerli R, Catanoso MG, Boiardi L, Cantini F, Klersy C, Hunder GG.

Ann Intern Med. 2007 May 1;146(9):631-9.

PMID:
17470831
5.

[Treatment of primary systemic vasculitis with TNF alpha-antagonists].

Gause A, Arbach O, Lamprecht P.

Z Rheumatol. 2003 Jun;62(3):228-34. German.

PMID:
12827398
6.

Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.

Woolacott N, Bravo Vergel Y, Hawkins N, Kainth A, Khadjesari Z, Misso K, Light K, Asseburg C, Palmer S, Claxton K, Bruce I, Sculpher M, Riemsma R.

Health Technol Assess. 2006 Sep;10(31):iii-iv, xiii-xvi, 1-239. Review.

7.

Tumour necrosis factor alpha inhibitors in the treatment of childhood uveitis.

Saurenmann RK, Levin AV, Rose JB, Parker S, Rabinovitch T, Tyrrell PN, Feldman BM, Laxer RM, Schneider R, Silverman ED.

Rheumatology (Oxford). 2006 Aug;45(8):982-9. Epub 2006 Feb 3.

PMID:
16461435
8.
9.

Etanercept, infliximab, and leflunomide in established rheumatoid arthritis: clinical experience using a structured follow up programme in southern Sweden.

Geborek P, Crnkic M, Petersson IF, Saxne T; South Swedish Arthritis Treatment Group..

Ann Rheum Dis. 2002 Sep;61(9):793-8.

10.

Fast recovery with etanercept in patients affected by polymyalgia rheumatica and decompensated diabetes: a case-series study.

Corrao S, Pistone G, Scaglione R, Colomba D, Calvo L, Licata G.

Clin Rheumatol. 2009 Jan;28(1):89-92. doi: 10.1007/s10067-008-1026-6. Epub 2008 Oct 23.

PMID:
18946712
11.

Canadian Rheumatology Association Consensus on the use of anti-tumor necrosis factor-alpha directed therapies in the treatment of spondyloarthritis.

Maksymowych WP, Inman RD, Gladman D, Thomson G, Stone M, Karsh J, Russell AS; Spondyloarthritis Research Consortium of Canada (SPARCC)..

J Rheumatol. 2003 Jun;30(6):1356-63. Review.

PMID:
12784417
12.

Anti-tumor necrosis factor therapy: 6 year experience of a single center in northern Israel and possible impact of health policy on results.

Braun-Moscovici Y, Markovits D, Rozin A, Toledano K, Nahir AM, Balbir-Gurman A.

Isr Med Assoc J. 2008 Apr;10(4):277-81.

13.

Anti-TNFalpha therapy in rheumatoid arthritis and autoimmunity.

Caramaschi P, Biasi D, Colombatti M, Pieropan S, Martinelli N, Carletto A, Volpe A, Pacor LM, Bambara LM.

Rheumatol Int. 2006 Jan;26(3):209-14. Epub 2004 Dec 31.

PMID:
15627197
14.

Drug survival of the first and second course of anti-tumour necrosis factor agents in juvenile idiopathic arthritis.

Tynjälä P, Vähäsalo P, Honkanen V, Lahdenne P.

Ann Rheum Dis. 2009 Apr;68(4):552-7. doi: 10.1136/ard.2007.087130. Epub 2008 May 8.

PMID:
18467515
15.

Characteristics and treatment responses of patients satisfying the BSR guidelines for anti-TNF in ankylosing spondylitis.

Gadsby K, Deighton C.

Rheumatology (Oxford). 2007 Mar;46(3):439-41. Epub 2007 Jan 25.

PMID:
17255137
16.

Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation.

Galor A, Perez VL, Hammel JP, Lowder CY.

Ophthalmology. 2006 Dec;113(12):2317-23. Epub 2006 Sep 25.

PMID:
16996615
17.
18.
19.
20.

Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis.

Hoffman GS, Merkel PA, Brasington RD, Lenschow DJ, Liang P.

Arthritis Rheum. 2004 Jul;50(7):2296-304.

Supplemental Content

Support Center